Sensus Healthcare is at the forefront of cutting-edge medical technology, specializing in advancing healthcare solutions for patients around the world.
Our expertise encompasses Superficial Radiotherapy, which offers state-of-the-art non-melanoma skin cancer treatment options, and comprehensive dermatological solutions designed to address a range of skin conditions. With a robust presence in international markets, our medical devices and innovative treatment options are transforming the way skin cancer and keloids are managed globally.
Our commitment to revolutionizing radiation oncology is evident in our deployment of advanced healthcare solutions tailored to meet the needs of diverse populations. By integrating the latest in radiotherapy technology, we provide clinicians with powerful tools for precise and effective non-melanoma skin cancer treatment.
Our global outreach ensures that cutting-edge radiation oncology techniques are accessible, making a profound impact on patient outcomes worldwide.
Dermatological innovations are at the heart of what we do, as we continuously enhance our devices, equipment and treatment solutions to challenging skin conditions. Our focus on non-melanoma skin cancer allows for customized dermatological solutions for curing challenging patient cases that can be implemented across the globe and reflects our dedication to providing high-quality care on an internation scale.
Superficial Radiotherapy also offers a unique, innovative treatment option for the treatment of keloids, which have historically proven troublesome to patients and healthcare providers alike. Through strategic international partnerships, we’re able to deliver sophisticated dermatological solutions to a broader audience, bridging gaps in global healthcare access.
Our international expansion efforts are driven by a desire to improve dermatological healthcare outcomes across the globe. By forging strong international partnerships, we leverage a network of expertise to deploy our advanced medical devices and clinical solutions in new markets. This collaborative approach not only strengthens our global presence but also facilitates the delivery of comprehensive solutions in Superficial Radiotherapy to diverse communities.
As leaders in the field of dermatological innovations in medical technology, our focus is on pioneering comprehensive healthcare solutions that address both immediate and long-term patient needs. From innovative treatment options in Superficial Radiotherapy to dermatological solutions that tackle non-melanoma skin cancer and keloids, our mission is to elevate the standard of care worldwide. With a commitment to global outreach and cutting-edge advancements, we continue to shape the future of healthcare across international boundaries.
Mr. Suen brings to Sensus nearly 20 years of business development, sales and regulatory experience supporting the distribution of U.S. medical devices and other products throughout Asia and in particular China. Most recently, he was Director, Business Development at Fosun Pharma, with responsibility for identifying complementary products to expand the Fosun/Chindex product portfolio and providing strategies for companies to enter the China market.
From 2010 to 2016 he was Senior Manager, Business Development and Regulatory at Chindex International, prior to its acquisition by Fosun Pharma. At Chindex, Mr. Suen was part of a team that initiated and managed the first robotic surgery reference center in China, and established one of the most successful da Vinci Surgical System marketing programs in the world. From 2004 to 2010 he served as Manager, Business Development at Prosperity Link in Beijing, where he was responsible for the annual sourcing of more than $50 million in food products from the U.S.
